John Peter Lydon

Dr. John Peter Lydon


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2008 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
JKJaeyeon Kim
Jaeyeon Kim
MSMarcey Sato
Marcey Sato
QLQuanxi Li
Quanxi Li
JLJohn Peter Lydon
John Peter Lydon
FDFrancesco John DeMayo
Francesco John DeMayo
MBMILAN BAGCHI
MILAN BAGCHI
The progesterone receptor (PR) plays a critical role during ovulation. Mice lacking the PR gene are anovulatory due to a failure in the rupture of the preovulatory follicles. The pathways that operate downstream of PR to control ovulation are poorly understood. Using gene expression profiling, we identified peroxisome proliferator-activated receptor γ (PPARγ) as a target of regulation by PR in the granulosa cells of the preovulatory follicles during the ovulatory process. To investigate the function of PPARγ during ovulation, we created a conditional knockout mouse in which this gene was deleted via Cre-Lox-mediated excision in granulosa cells. When these mutant mice were subjected to gonadotropin-induced superovulation, the preovulatory follicles failed to rupture and the number of eggs released from the mutant ovaries declined drastically. Gene expression analysis identified endothelin-2, interleukin-6, and cyclic GMP-dependent protein kinase II as novel targets of regulation by PPARγ in the ovary. Our studies also suggested that cycloxygenase 2-derived metabolites of long-chain fatty acids function as endogenous activating ligands of PPARγ in the preovulatory follicles. Collectively, these studies revealed that PPARγ is a key mediator of the biological actions of PR in the granulosa cells and activation of its downstream pathways critically controls ovulation.

1 July 2020 in Journal of Molecular Endocrinology
Verified
Journal Article
Open access
PDF file
FDFrancesco J DeMayo
Francesco J DeMayo
JLJohn Peter Lydon
John Peter Lydon
Progesterone’s ability to maintain pregnancy in eutherian mammals highlighted this steroid as the ‘hormone of pregnancy’. It was the unique ‘pro-gestational’ bioactivity of progesterone that enabled eventual purification of this ovarian steroid to crystalline form by Willard Myron Allen in the early 1930s. While a functional connection between normal progesterone responses (’progestational proliferation’) of the uterus with the maintenance of pregnancy was quickly appreciated, an understanding of progesterone’s involvement in the early stages of pregnancy establishment was comparatively less well understood. With the aforementioned as historical backdrop, this review focuses on a selection of key advances in our understanding of the molecular mechanisms by which progesterone, through its nuclear receptor (the progesterone receptor), drives the development of endometrial receptivity, a transient uterine state that allows for embryo implantation and the establishment of pregnancy. Highlighted in this review are the significant contributions of advanced mouse engineering and genome-wide transcriptomic and cistromic analytics which reveal the pivotal molecular mediators and modifiers that are essential to progesterone-dependent endometrial receptivity and decidualization. With a clearer understanding of the molecular landscape that underpins uterine responsiveness to progesterone during the periimplantation period, we predict that common gynecologic morbidities due to abnormal progesterone responsiveness will be more effectively diagnosed and/or treated in the future.

15 December 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
OKOlga Kim
Olga Kim
EPEun Young Park
Eun Young Park
SKSun Young Kwon
Sun Young Kwon
SSSojin Shin
Sojin Shin
RERobert E. Emerson
Robert E. Emerson
JKJaeyeon Kim
Jaeyeon Kim
Significance: Why women carrying a pathogenic germlineBRCA1mutation are predisposed to ovarian and breast cancer remains elusive. This study points to ovarian progesterone as a culprit. Generally,BRCA1-mutation carriers exhibit high yet individually varying levels of progesterone during the menstrual cycle. Although not allBRCA1-mutation carriers develop these cancers, all of them are advised to undergo prophylactic surgeries at a young age (under 40 y to 45 y) to prevent ovarian and breast cancer. Insights from robust in vivo findings in this study offer a novel concept: Targeting progesterone signaling with antiprogestins could be an effective nonsurgical prophylactic option for ovarian and breast cancer prevention for these high-risk women.

27 September 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
AKAndrew M. Kelleher
Andrew M. Kelleher
RSRohit Setlem
Rohit Setlem
FDFrançoise Dantzer
Françoise Dantzer
FDFrancesco John DeMayo
Francesco John DeMayo
JLJohn Peter Lydon
John Peter Lydon
WKW. Lee Kraus
W. Lee Kraus
Miscarriage is a common complication of pregnancy for which there are few clinical interventions. Deficiency in endometrial stromal cell decidualization is considered a major contributing factor to pregnancy loss; however, our understanding of the underlying mechanisms of decidual deficiency are incomplete. ADP ribosylation by PARP-1 and PARP-2 has been linked to physiological processes essential to successful pregnancy outcomes. Here, we report that the catalytic inhibition or genetic ablation of PARP-1 and PARP-2 in the uterus lead to pregnancy loss in mice. Notably, the absence of PARP-1 and PARP-2 resulted in increased p53 signaling and an increased population of senescent decidual cells. Molecular and histological analysis revealed that embryo attachment and the removal of the luminal epithelium are not altered in uterine Parp1, Parp2 knockout mice, but subsequent decidualization failure results in pregnancy loss. These findings provide evidence for a previously unknown function of PARP-1 and PARP-2 in mediating decidualization for successful pregnancy establishment. Significance This study identifies an unknown role for PARP-1 and PARP-2 in mediating pregnancy success. Utilizing a combination of mouse genetic models, pharmacological inhibitors, and histological and transcriptomic analysis, we identified roles for PARPs and ADP ribosylation (ADPRylation) during the establishment and maintenance of pregnancy. We show that the absence of PARP-1 and PARP-2 augments the DNA damage response during early pregnancy, presumably by ADPRylating substrate proteins, culminating in aberrant decidualization and ultimately pregnancy failure. These findings could be leveraged to develop contraceptives or as biomarkers of uterine receptivity and stromal cell decidualization.

11 March 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MPMary C. Peavey
Mary C. Peavey
SWSan-Pin Wu
San-Pin Wu
RLRong Li
Rong Li
JLJian Liu
Jian Liu
OEOlivia M. Emery
Olivia M. Emery
FDFrancesco John DeMayo
Francesco John DeMayo
Uterine contractile dysfunction leads to pregnancy complications such as preterm birth and labor dystocia. In humans, it is hypothesized that progesterone receptor isoform PGR-B promotes a relaxed state of the myometrium, and PGR-A facilitates uterine contraction. This hypothesis was tested in vivo using transgenic mouse models that overexpress PGR-A or PGR-B in smooth muscle cells. Elevated PGR-B abundance results in a marked increase in gestational length compared to control mice (21.1 versus 19.1 d respectively, P < 0.05). In both ex vivo and in vivo experiments, PGR-B overexpression leads to prolonged labor, a significant decrease in uterine contractility, and a high incidence of labor dystocia. Conversely, PGR-A overexpression leads to an increase in uterine contractility without a change in gestational length. Uterine RNA sequencing at midpregnancy identified 1,174 isoform-specific downstream targets and 424 genes that are commonly regulated by both PGR isoforms. Gene signature analyses further reveal PGR-B for muscle relaxation and PGR-A being proinflammatory. Elevated PGR-B abundance reduces Oxtr and Trpc3 and increases Plcl2 expression, which manifests a genetic profile of compromised oxytocin signaling. Functionally, both endogenous PLCL2 and its paralog PLCL1 can attenuate uterine muscle cell contraction in a CRISPRa-based assay system. These findings provide in vivo support that PGR isoform levels determine distinct transcriptomic landscapes and pathways in myometrial function and labor, which may help further the understanding of abnormal uterine function in the clinical setting. Significance Preterm birth affects 10 to 12% of all pregnancies and is the primary cause of neonatal morbidity and mortality worldwide, while prolonged labor increases the risks of infection, uterine rupture, and neonatal distress. Progesterone suppresses uterine contractions. As humans maintain high levels of progesterone throughout parturition, a “functional progesterone withdrawal” hypothesis suggests that switching between myometrial PGR-A and PGR-B isoform activities is crucial for transitioning into the parturition mode. Our mouse models provide evidence in support of this hypothesis. These findings also demonstrate a significant difference in downstream transcriptomic landscapes between the two PGR isoforms. Therefore, this work opens a venue to investigate the PGR isoform interacting signaling for parturition control, providing a possible pathway for developing clinical therapies.

7 April 2021 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
VMVineet K. Maurya
Vineet K. Maurya
FDFrancesco J. DeMayo
Francesco J. DeMayo
JLJohn Peter Lydon
John Peter Lydon
Synchrony between progesterone-driven endometrial receptivity and the arrival of a euploid blastocyst is essential for embryo implantation, a prerequisite event in the establishment of a successful pregnancy. Advancement of embryo implantation within the uterus also requires stromal fibroblasts of the endometrium to transform into epithelioid decidual cells, a progesterone-dependent cellular transformation process termed decidualization. Although progesterone is indispensable for these cellular processes, the molecular underpinnings are not fully understood. Because human studies are restricted, much of our fundamental understanding of progesterone signaling in endometrial periimplantation biology comes fromin vitroandin vivoexperimental systems. In this review, we focus on the tremendous progress attained with the use of engineered mouse models together with high throughput genome-scale analysis in disclosing key signals, pathways and networks that are required for normal endometrial responses to progesterone during the periimplantation period. Many molecular mediators and modifiers of the progesterone response are implicated in cross talk signaling between epithelial and stromal cells of the endometrium, an intercellular communication system that is critical for the ordered spatiotemporal control of embryo invasion within the maternal compartment. Accordingly, derailment of these signaling systems is causally linked with infertility, early embryo miscarriage and gestational complications that symptomatically manifest later in pregnancy. Such aberrant progesterone molecular responses also contribute to endometrial pathologies such as endometriosis, endometrial hyperplasia and cancer. Therefore, our review makes the case that further identification and functional analysis of key molecular mediators and modifiers of the endometrial response to progesterone will not only provide much-needed molecular insight into the early endometrial cellular changes that promote pregnancy establishment but lend credible hope for the development of more effective mechanism-based molecular diagnostics and precision therapies in the clinical management of female infertility, subfertility and a subset of gynecological morbidities.